Gujarat Themis Biosyn LtdPharmaceuticalsINE942C01045Consolidated₹414.40-13.25 (-3.10%)Jun-26
Valuation
Market Cap₹4.52K Cr
TTM PE406.27x
Forward PE-29.10x
PEG644.87
Book Value₹26.41
P/B15.69x
TTM EPS₹1.02
Fwd EPS₹-14.24
TTM Revenue₹165.82 Cr
TTM PAT₹46.68 Cr
TTM EBITDA₹75.53 Cr
TTM EBIT₹62.61 Cr
Last Qtr PAT₹11.07 Cr
Last Qtr EBITDA₹75.53 Cr
Last Qtr EBIT₹62.61 Cr
Profitability
ROE16.22%
ROCE4.52%
TTM NPM28.15%
TTM EBITDA %45.55%
Curr OPM25.20%
Last OPM-8.41%
Curr NPM
Last NPM
Curr EPS₹1.02
Last EPS₹-4.82
Balance sheet
Equity₹10.90 Cr
Reserve₹276.86 Cr
Total Debt₹161.81 Cr
D/E0.56x
Interest %16.17%
Curr Interest₹1.79 Cr
Price / range
Close₹414.40
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D-3.10%
1W-2.11%
1M+8.79%
3M+8.16%
6M+50.64%
1Y+7.45%
2Y+13.22%
3Y+261.38%
5Y+402.12%
Diwali-5.81%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1868.90₹4.48L Cr37.0814.50%
DIVISLAB9410.50₹2.50L Cr85.3917.45%
TORNTPHARM4970.00₹1.89L Cr79.3925.70%
ZYDUSLIFE1161.00₹1.16L Cr25.8716.94%
CIPLA1386.10₹1.12L Cr33.219.75%
LAURUSLABS2017.50₹1.09L Cr99.5820.58%
MANKIND2437.80₹1.01L Cr49.2612.68%
DRREDDY1198.30₹1.00L Cr30.978.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue43.79+22.1%44.2343.3742.3535.87165.82
Other Income0.130.920.420.820.272.43
Total Income43.92+21.5%45.1543.7843.1736.15168.25
Interest1.791.910.960.040.042.95
Expenditure-28.76-19.7%-30.82-26.91-24.40-24.03-106.16
PBDT000000
EBITDA20.79+49.5%19.3621.3120.9513.9175.53
Depreciation-3.97-4.04-3.89-2.96-2.03-12.92
EBIT16.82+41.6%15.3217.4217.9911.8862.61
PBT15.17+25.2%14.3416.8718.7612.1262.09
Tax-4.10-3.45-4.41-4.50-3.06-15.41
Equity10.9010.900010.9010.90
OPM34.5431.7638.9144.3133.5336.90
Net Profit11.07+22.2%10.8912.4714.279.0646.68
NPM25.2024.1228.7433.6925.0627.75
EPS1.02+22.9%01.141.310.830

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue165.82+10.0%150.80-11.2%169.82+14.0%148.97+29.7%114.85+26.8%90.56
Other Income2.432.434.376.024.053.27
Total Income168.25+9.8%153.23-12.0%174.19+12.4%155+30.4%118.90+26.7%93.83
Expenditure-106.16-21.1%-87.69+7.5%-94.85-22.3%-77.53-29.5%-59.87-13.1%-52.95
Interest-2.95-0.36-0.23-0.20-0.83-0.98
PBDT000000
EBITDA75.53+9.7%68.84-12.6%78.74+6.1%74.22+27.9%58.04+43.9%40.32
Depreciation-12.92-5.37-3.54-2.58-2.23-1.73
EBIT62.61-1.4%63.47-15.6%75.20+5.0%71.64+28.4%55.81+44.6%38.59
PBT62.09-5.3%65.54-17.4%79.33+2.4%77.47+31.2%59.04+44.4%40.88
Tax-15.41-16.77-20.17-19.50-15.41-10.70
Equity10.9010.900000
OPM (%)36.9042.7746.0050.0050.0044.00
Net Profit46.68-4.3%48.77-17.6%59.16+2.1%57.97+32.9%43.62+44.5%30.18
NPM (%)27.7531.8334.0037.0037.0032.00
EPS (Rs)0-100.0%4.48-45.0%8.14-79.6%39.90+32.9%30.03+44.6%20.77
CEPS04.488.1439.9030.0320.77

Consolidated

16 lines · 2 periods
MetricJun-26FY25-26
Revenue43.79165.82
Other Income0.132.43
Total Income43.92168.25
Interest1.792.95
Expenditure-28.76-106.16
PBDT00
EBITDA20.7975.53
Depreciation-3.97-12.92
EBIT16.8262.61
PBT15.1762.09
Tax-4.10-15.41
Equity10.9010.90
OPM34.5436.90
Net Profit11.0746.68
NPM25.2027.75
EPS1.020

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue165.82+10.0%150.80
Other Income2.432.43
Total Income168.25+9.8%153.23
Expenditure-106.16-21.1%-87.69
Interest-2.95-0.36
PBDT00
EBITDA75.53+9.7%68.84
Depreciation-12.92-5.37
EBIT62.61-1.4%63.47
PBT62.09-5.3%65.54
Tax-15.41-16.77
Equity10.9010.90
OPM (%)36.9042.77
Net Profit46.68-4.3%48.77
NPM (%)27.7531.83
EPS (Rs)0-100.0%4.48
CEPS04.48

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

9
YearTypeAmountEx-Date
2025Final Dividend0.6704 Sep 2025
2024Final Dividend0.2515 Jul 2024
2024Interim Dividend0.7522 Feb 2024
2023Final Dividend101 Sep 2023
2023Interim Dividend4.402 Dec 2022
2022Final Dividend429 Aug 2022
2022Interim Dividend224 Nov 2021
Special Dividend524 Nov 2021
2020Final Dividend1.6510 Sep 2020

Bonus

1
YearRatioEx-Date
20241:209 Aug 2024

Split

1
YearRatioEx-Date
2023Rs.5/- to Rs.1/-10 Oct 2023
Loading company dashboard...
Fetching ratios, charts, and peers